1 – 3 of 3
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity
(
- Contribution to journal › Article
- 2022
-
Mark
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
2022) In Acta Neuropathologica(
- Contribution to journal › Article
- 2015
-
Mark
CSF biomarkers for the differential diagnosis of Alzheimer's disease. A large-scale international multicenter study.
(
- Contribution to journal › Article